(Q44765320)

6 December 2017

title

Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy (English)

1 reference

6 December 2017

0 references

Magnhild Sandberg-Wollheim

1

1 reference

6 December 2017

Enrica Alteri

2

1 reference

6 December 2017

Margaretha Stam Moraga

3

1 reference

6 December 2017

Gabrielle Kornmann

4

1 reference

6 December 2017

publication date

10 January 2011

1 reference

Multiple Sclerosis Journal

6 December 2017

published in

1 reference

6 December 2017

volume

17

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

423-430

1 reference

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

Pregnancy and multiple sclerosis: the initial results from a Brazilian database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

Reproductive counselling, treatment and course of pregnancy in 73 German MS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

Interferon-beta1b in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

Multiple sclerosis: management issues during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394610

21 January 2018

Identifiers

DOI

10.1177/1352458510394610

1 reference

6 December 2017

1 reference